Bot, Adrian,Qiu, Zhiyong,Smith, Kent Andrew,Kundig, Thomas
申请号：
AU2014201422
公开号：
AU2014201422B2
申请日:
2014.03.12
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
#$%^&*AU2014201422B220160331.pdf#####The present invention provides for uses of a plurality of sequential doses of an immunogenic composition for stimulating a class I MHC-restricted T cell response in the treatment or prevention of an infectious or neoplastic disease wherein each dose subsequent to an initial dose is greater than the immediately preceding dose, and wherein the sequential doses increase as a linear or exponential function of the initial dose, and wherein the last dose of the sequential doses of the immunogenic composition is administered within 10 days after the first dose of the sequential doses of the immunogenic composition.
